X hits on this document

11 views

0 shares

0 downloads

0 comments

4 / 5

Table III: ICRP and Manufacturers' Data on Effective Doses, Total Body Doses, and Absorbed Doses per Unit Activity of Other Radiopharmaceuticals

Radiopharmaceutical

201Tl

99mTc labeled erythrocytes

82Rb

13N-ammonia

15O-water

18F-FDG

Data Source

ICRP 53A5

PI 1

PI 2

PI 3

ICRP 80

PI

ICRP 80

PI

ICRP 80

ICRP 53A5

ICRP 80

Effective Dose (E/A in mSv/MBq)

1.7E-01

3.6E-01

-

3.6E-01

7.0E-03

-

3.4E-03

-

2.0E-03

1.1E-03

1.9E-02

Total Body Dose (in mGy/MBq)

-

-

5.9E-02

-

-

4.1E-03

-

4.3E-04

-

-

-

Data Source

ICRP 53A5

PI 1

PI 2

PI 3

ICRP 80

PI

ICRP 53

PI

ICRP 53

ICRP 53A5

ICRP 80

Organ Absorbed Doses (DT/A in mGy/MBq)

    Adrenals

5.8E-02

6.2E-02

6.5E-02

9.9E-03

2.0E-02

9.7E-04

2.3E-03

1.4E-03

1.2E-02

    Bladder

4.1E-02

5.2E-02

5.3E-02

8.5E-03

6.5E-03

1.7E-04

8.1E-03

2.6E-04

1.6E-01

    Bone

3.8E-01

8.8E-02

8.9E-02

7.4E-03

6.5E-03

6.7E-04

6.6E-06

1.6E-03

6.3E-04

1.1E-02

    Bone Marrow

1.1E-01

5.5E-02

5.6E-02

6.1E-03

4.1E-03

9.9E-04

3.8E-04

1.7E-03

8.9E-04

1.1E-02

    Brain

2.3E-02

5.9E-02

6.1E-02

3.6E-03

4.2E-03

1.3E-03

2.8E-02

    Breasts

2.5E-02

3.6E-02

3.6E-02

3.5E-03

1.9E-04

1.8E-03

2.8E-04

8.6E-03

    Colon

2.5E-01

3.7E-03

1.6E-03

1.3E-02

    Colon (lower large intestine)

3.4E-01

3.4E-01

5.9E-02

3.4E-01

3.4E-03

3.9E-03

8.6E-04

1.9E-03

1.6E-03

1.5E-02

    Colon (upper large intestine)

1.8E-01

3.3E-01

7.0E-02

3.3E-01

4.0E-03

3.9E-03

8.6E-04

1.8E-03

1.6E-03

1.2E-02

    Esophagus

3.6E-02

6.1E-03

3.3E-04

1.1E-02

    Gallbladder

6.6E-02

8.3E-02

8.4E-02

6.5E-03

4.5E-04

1.2E-02

    Heart

1.9E-01

2.8E-01

1.4E-01

2.8E-01

2.3E-02

2.7E-02

3.3E-03

1.9E-03

2.1E-03

1.9E-03

6.2E-02

    Kidneys

4.8E-01

4.6E-01

3.2E-01

4.6E-01

1.8E-02

1.8E-02

8.7E-03

4.6E-03

1.7E-03

2.1E-02

    Liver

1.5E-01

9.9E-02

1.6E-01

9.9E-02

1.3E-02

7.8E-03

9.7E-04

8.7E-04

4.0E-03

1.6E-03

1.1E-02

    Lungs

1.1E-01

4.7E-02

4.8E-02

1.8E-02

2.4E-03

1.7E-03

2.5E-03

1.6E-03

1.0E-02

    Muscles

5.2E-02

4.6E-02

4.7E-02

3.3E-03

2.9E-04

1.1E-02

    Ovaries

1.2E-01

1.0E-01

1.3E-01

1.0E-01

3.7E-03

4.3E-03

2.4E-04

3.8E-04

1.7E-03

8.5E-04

1.5E-02

    Pancreas

5.8E-02

7.4E-02

7.5E-02

6.6E-03

4.5E-03

6.3E-04

1.9E-03

1.4E-03

1.2E-02

    Remaining Organs

5.4E-02

3.5E-03

1.1E-02

2.3E-04

1.6E-03

4.0E-04

1.1E-02

    Salivary Glands

    Skin

2.2E-02

3.3E-01

3.4E-02

2.0E-03

2.5E-04

8.0E-03

    Small Intestine

1.4E-01

4.5E-01

1.1E-01

4.5E-01

3.9E-03

3.9E-03

1.4E-03

1.8E-03

1.3E-03

1.3E-02

    Spleen

1.2E-01

1.8E-01

1.8E-01

1.4E-02

3.0E-02

5.0E-03

2.5E-03

1.6E-03

1.1E-02

    Stomach

1.2E-01

1.9E-01

1.1E-01

1.9E-01

4.6E-03

3.8E-03

8.6E-04

1.7E-03

1.7E-03

1.1E-02

    Testes

4.5E-01

8.2E-01

1.5E-01

8.3E-01

2.3E-03

3.0E-03

1.3E-04

3.0E-04

1.8E-03

7.4E-04

1.2E-02

    Thalamus

4.7E-02

    Thymus

3.6E-02

4.6E-02

6.1E-03

3.3E-04

1.1E-02

    Thyroid

2.2E-01

6.2E-01

1.3E-01

6.2E-01

5.7E-03

3.8E-02

1.7E-03

1.5E-03

1.0E-02

    Uterus

5.1E-02

8.5E-02

8.6E-02

3.9E-03

2.1E-04

1.9E-03

3.5E-04

2.1E-02

ICRP 53A5 denotes ICRP Publication 53 Addendum 5.  Three manufacturers currently produce 201Tl for medical use in the United States; their PIs are referred to as PI 1, PI 2, and PI 3.

Document info
Document views11
Page views11
Page last viewedFri Dec 02 04:12:16 UTC 2016
Pages5
Paragraphs795
Words1774

Comments